Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,925 | -52,539 | -38,050 | -26,876 | -94,226 |
| Depreciation Amortization | 37,627 | 28,223 | 18,816 | 9,409 | 37,697 |
| Accounts receivable | 994 | 17,692 | 20,712 | 21,553 | 11,297 |
| Other Working Capital | -20,727 | -4,521 | -315 | -3,176 | -1,443 |
| Other Operating Activity | 10,647 | -9,931 | -15,072 | -18,448 | -26,479 |
| Operating Cash Flow | $-23,384 | $-21,076 | $-13,909 | $-17,538 | $-73,154 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -114 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-114 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | -33,000 |
| Debt Repayment | -32,000 | -24,000 | -24,000 | -16,000 | N/A |
| Common Stock Issued | 6,794 | 84 | 34 | 34 | 7,598 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 40,000 |
| Financing Cash Flow | $-25,206 | $-23,916 | $-23,966 | $-15,966 | $14,598 |
| Beginning Cash Position | 93,169 | 93,169 | 93,169 | 93,169 | 151,839 |
| End Cash Position | 44,579 | 48,177 | 55,294 | 59,665 | 93,169 |
| Net Cash Flow | $-48,590 | $-44,992 | $-37,875 | $-33,504 | $-58,670 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,384 | -21,076 | -13,909 | -17,538 | -73,154 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -114 |
| Free Cash Flow | -23,384 | -21,076 | -13,909 | -17,538 | -73,268 |